AstraZeneca shares in demand after HSBC upgrade
Nudging up the valuation by 140p to 7,260p each, the bank said the main oncology pillars of the group – Lynparza, Tagrisso and Imfinzi – showed robust growth in the third quarter
Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1084 stories · page 27 of 55
AstraZeneca posts positive late-stage trial results for asthma treatment
The drug candidate, developed with Amgen, was found to be effective and safe
Coronavirus: Hospitals told to be ready for COVID-19 vaccine by month-end
It would first be distributed to care home residents, people over 80 and healthcare workers
AstraZeneca receives EU approval for leukaemia treatment
The green light follows positive results from two Phase III clinical trials and a recommendation for approval by an EU committee
AstraZeneca's Brilinta get approval for use in stroke alongside aspirin
The US Food & Drug Administration green light followed a successful phase III study of the drug, also known as ticagrelor, in combination with aspirin
AstraZeneca posts lukewarm quarterly results as two candidates get EU approval
The drugs firm said it is on track to achieve full-year results in line with guidance despite quarterly revenue only being up 3%
Small chance of vaccine by Christmas says head of Oxford/AstraZeneca trial
Reports yesterday suggested the GPs had been told to prepare to administer a COVID-19 vaccine before Christmas.
AstraZeneca to sell heart failure treatment commercial rights for US$400mln
The buyer is German pharma company Cheplapharm while the agreement will cover over 70 countries
AstraZeneca says COVID-19 vaccine candidate provokes similar immune response in older, younger adults
Efficacy read-outs from the final phase of trials are expected "between now and the end of the year"
London hospitals told to be ready to receive AstraZeneca COVID-19 vaccine: media reports
Health Secretary Matt Hancock said vaccinating health workers was not his “central expectation” though he did not rule it out
AstraZeneca says Tagrisso granted priority review in US
It is being investigated as an additional treatment of patients with early-stage non-small cell lung cancer
AstraZeneca receives recommendation for approval for two candidates from EU committee
The recommendation was based on final-stage trial results for both Forxiga and Trixeo Aerosphere
AstraZeneca to begin late-stage trials on COVID-19 antibody prevention candidate
The US government has provided funding of US$486mln to progress the studies
Liberum hikes target price for AstraZeneca on Daiichi Sankyo collaboration prospects
The pair are developing cancer drug DS-1062 as part of a US$6bn partnership
Coronavirus: CEPI creates labs network to standardise vaccines testing
The organisation partnered with five clinical laboratories worldwide
AstraZeneca coronavirus vaccine to face deeper scrutiny by US regulator
A trial of the vaccine has already been halted in the US
AstraZeneca granted breakthrough therapy designation for Farxiga
The candidate showed promising results in early trials
AstraZeneca and GlaxoSmithKline shares still a good investment, says Berenberg
Big pharma is forecast to return 46% of operating cash flow in the form of dividends and 10% in share buybacks between 2020 and 2024
Vaccines remain the key as coronavirus second wave anxiety mounts among investors
There are more than six vaccines in late-stage trials currently
Archive
AstraZeneca criticised by US experts over COVID-19 vaccine trial halt
US scientists are concerned about the potential neurological adverse effects of the jab